rs77890266

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014855.3(AP5Z1):​c.1529G>A​(p.Arg510Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0207 in 1,574,254 control chromosomes in the GnomAD database, including 434 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 34 hom., cov: 32)
Exomes 𝑓: 0.021 ( 400 hom. )

Consequence

AP5Z1
NM_014855.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.11
Variant links:
Genes affected
AP5Z1 (HGNC:22197): (adaptor related protein complex 5 subunit zeta 1) This gene was identified by genome-wide screen for genes involved in homologous recombination DNA double-strand break repair (HR-DSBR). The encoded protein was found in a complex with other proteins that have a role in HR-DSBR. Knockdown of this gene reduced homologous recombination, and mutations in this gene were found in patients with spastic paraplegia. It was concluded that this gene likely encodes a helicase (PMID:20613862). [provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033444464).
BP6
Variant 7-4788228-G-A is Benign according to our data. Variant chr7-4788228-G-A is described in ClinVar as [Benign]. Clinvar id is 240935.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-4788228-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.016 (2441/152230) while in subpopulation SAS AF= 0.0257 (124/4824). AF 95% confidence interval is 0.0226. There are 34 homozygotes in gnomad4. There are 1159 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 34 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP5Z1NM_014855.3 linkc.1529G>A p.Arg510Gln missense_variant Exon 12 of 17 ENST00000649063.2 NP_055670.1 O43299-1
AP5Z1NM_001364858.1 linkc.1061G>A p.Arg354Gln missense_variant Exon 11 of 16 NP_001351787.1
AP5Z1XM_047421098.1 linkc.1193G>A p.Arg398Gln missense_variant Exon 10 of 15 XP_047277054.1
AP5Z1NR_157345.1 linkn.1660G>A non_coding_transcript_exon_variant Exon 12 of 17

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP5Z1ENST00000649063.2 linkc.1529G>A p.Arg510Gln missense_variant Exon 12 of 17 NM_014855.3 ENSP00000497815.1 O43299-1

Frequencies

GnomAD3 genomes
AF:
0.0160
AC:
2441
AN:
152112
Hom.:
33
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00432
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0180
Gnomad ASJ
AF:
0.0320
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.0257
Gnomad FIN
AF:
0.00640
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0235
Gnomad OTH
AF:
0.0239
GnomAD3 exomes
AF:
0.0181
AC:
3362
AN:
186222
Hom.:
40
AF XY:
0.0185
AC XY:
1866
AN XY:
100728
show subpopulations
Gnomad AFR exome
AF:
0.00434
Gnomad AMR exome
AF:
0.0147
Gnomad ASJ exome
AF:
0.0338
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0221
Gnomad FIN exome
AF:
0.00595
Gnomad NFE exome
AF:
0.0232
Gnomad OTH exome
AF:
0.0257
GnomAD4 exome
AF:
0.0212
AC:
30196
AN:
1422024
Hom.:
400
Cov.:
31
AF XY:
0.0215
AC XY:
15166
AN XY:
703940
show subpopulations
Gnomad4 AFR exome
AF:
0.00368
Gnomad4 AMR exome
AF:
0.0160
Gnomad4 ASJ exome
AF:
0.0324
Gnomad4 EAS exome
AF:
0.0000267
Gnomad4 SAS exome
AF:
0.0229
Gnomad4 FIN exome
AF:
0.00675
Gnomad4 NFE exome
AF:
0.0227
Gnomad4 OTH exome
AF:
0.0238
GnomAD4 genome
AF:
0.0160
AC:
2441
AN:
152230
Hom.:
34
Cov.:
32
AF XY:
0.0156
AC XY:
1159
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.00433
Gnomad4 AMR
AF:
0.0179
Gnomad4 ASJ
AF:
0.0320
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.0257
Gnomad4 FIN
AF:
0.00640
Gnomad4 NFE
AF:
0.0235
Gnomad4 OTH
AF:
0.0237
Alfa
AF:
0.0222
Hom.:
18
Bravo
AF:
0.0172
TwinsUK
AF:
0.0243
AC:
90
ALSPAC
AF:
0.0200
AC:
77
ESP6500AA
AF:
0.00315
AC:
12
ESP6500EA
AF:
0.0240
AC:
197
ExAC
AF:
0.0146
AC:
1733
Asia WGS
AF:
0.00895
AC:
31
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Feb 20, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary spastic paraplegia 48 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary spastic paraplegia Benign:1
Oct 09, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Aug 19, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.066
T;T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.85
.;D
MetaRNN
Benign
0.0033
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;L
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.6
N;.
REVEL
Benign
0.050
Sift
Benign
0.23
T;.
Sift4G
Benign
0.077
T;.
Polyphen
0.61
P;P
Vest4
0.072
ClinPred
0.010
T
GERP RS
2.6
Varity_R
0.058
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77890266; hg19: chr7-4827859; COSMIC: COSV100804023; COSMIC: COSV100804023; API